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Abstract
The leukoencephalopathies with cystic changes form a distinct subtype of childhood onset neurodegenerative 
disorders. This group has heterogeneous etiological differentials that primarily include mitochondrial disorders, some 
leukodystrophies and central nervous system infections. We report this case of a 17-month old girl who presented with 
seizures, episodic encephalopathy, elevated blood lactate level and lactate peak on magnetic resonance spectroscopy, 
a typical imaging picture noted on cranial magnetic resonance imaging and absence of deletions or duplications of 
mitochondrial deoxyribonucleic acid. Progressive cavitating leukoencephalopathy (PCL) is a recently described entity 
with only a few cases reported so far. We report the first case of PCL from India. Accurate diagnosis can be made, not 
only, by the presence of typical clinicoradiological findings of PCL, but also by the awareness of, and, ruling out of, 
the various other differential diagnoses that are discussed in detail below.
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The childhood onset leukoencephalopathies have a heterogeneous etiology. Leukoencephalopathies with cystic changes 
are a distinct subgroup; that have been characterized 
in the recent years by their typical radiological and 
clinical findings [1,2]. Naidu et al. described a series of 
19 patients from 16 families with episodic acute clinical 
deterioration associated with focally enhancing white 
matter (WM) lesions on the cranial magnetic resonance 
imaging (MRI) that progressed to multifocal cystic 
degeneration without any identifiable cause. Early 
lesions predominantly affected corpus callosum (CC), 
centrum semiovale (CSO), deep cerebral WM with 
or without the involvement of the cerebellum and the 
spinal cord. Later after repeated episodes, areas of 
tissue loss coalesce with older lesions to form larger 
cystic regions in brain and spinal cord. Gray matter 
is usually spared until the later stages. Eventually 
spasticity, seizures, dementia, vegetative state and 
death ensues. This clinical course may vary from 
rapid deterioration to prolonged periods of symptom 
stability. Familial occurrence and consanguinity in 
some families suggested an autosomal recessive 
inheritance. This entity was described as progressive 
cavitating leukoencephalopathy (PCL) in view of 
its unique clinical and radiological features with no 
apparent identifiable etiology [3].
CASE REPORT
A 17-month-old female child born of third degree 
consanguineous parentage was brought for evaluation of 
intermittent episodes of acute encephalopathy. The child 
had been well until 8 months of age, when she suddenly 
became ill with extreme irritability, inconsolable 
cry alternating with drowsiness and lethargy. She 
was hospitalized and managed as acute encephalitis. 
Hematological, biochemical and septic work up, as well 
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as cerebrospinal fluid (CSF) study were unremarkable 
at this time; except for significant lactic acidosis (blood 
lactate was 10.5 mmol/L; normal range up to 2 mmol/L). 
Subsequently, after this episode, her development 
plateaued. At 15 months, symptoms recurred in the form 
of a shrill cry, recurrent arching of the body, punctuated 
by spells of lethargy and drowsiness, which resolved 
spontaneously over 2 days. After this episode, the child 
was noted to have poorer visual responses. At 17 months, 
child was able to stand with support but unable to walk, 
sat unsupported and had a vocabulary of two single 
words (amma, appa). Examination revealed a normal 
head circumference (HC - 47.1 cm), no dysmorphic 
features, bilateral corticospinal signs, and bilateral optic 
atrophy on fundus examination.
Laboratory investigations, including 
creatinine phosphokinase, and CSF study were 
unremarkable except for an elevated blood lactate 
(7.5 mmol/L). Neurophysiologic studies, including 
electroencephalogram, nerve conduction study and 
needle electromyography were normal. Tandem 
mass spectrometry, specifically to rule out glycine 
leukoencephalopathy, was within normal limits. Study 
of the mitochondrial genome did not show deletions 
or duplications.
Contrast-enhanced cranial MRI showed WM 
T2 hyperintensities with fluid-attenuated inversion 
recovery hypointensities in bilateral periventricular 
areas, adjacent bilateral CSO and CC (Fig. 1a and b). 
Lesions were T1 hypointense in T1W images (Fig. 2a). 
CC lesions showed restricted diffusion, and low 
apparent diffusion coefficient values probably due to 
active demyelination in these regions (Fig. 3a and b). 
There was no significant diffusion restriction in 
periventricular lesions and CSO. Subcortical U fibers 
were entirely spared. Basal ganglia, thalami, brainstem, 
cerebellum and upper cervical cord were unaffected. 
Gadolinium-enhanced images showed patchy 
enhancement in the lesion of left CSO and intense areas 
of focal homogeneous enhancement in callosal lesions 
(Fig. 2b). Magnetic resonance spectroscopy (MRS) 
showed elevated lactate, low N-acetylaspartate and 
choline levels in cystic areas of WM lesions (Fig. 4).
The age of onset, parental consanguinity, episodes 
of acute unexplained encephalopathy, progressive 
neurological deficits (in this case slowing of 
development and visual impairment), typical MRI and 
MRS picture, normal CSF and metabolic studies and 
significant lactic acidosis with a normal mitochondrial 
genomic study lead to diagnosis of PCL in this case.
DISCUSSION
Neurological deterioration with cystic leukodystrophic 
changes should preempt differentials of 
megalencephalic leukoencephalopathy with subcortical 
cysts (MLC), Alexander’s disease, acute disseminated 
encephalomyelitis (ADEM), autosomal dominant acute 
necrotizing encephalopathy (ADANE), hemophagocytic 
Figure 2: (a and b) Magnetic resonance imaging 
findings showing features suggestive of progressive 
cavitating leukoencephalopathy. Sagittal T1 (a) and 
gadolinium enhanced (b) images demonstrating 
hypointense corpus callosal lesions (arrows) 
showing homogeneous & solid enhancement on 
intravenous gadolinium
ba
Figure 1: (a and b) Magnetic resonance imaging 
findings showing features suggestive of progressive 
cavitating leukoencephalopathy. (a) Axial T2 and 
(b) fluid-attenuated inversion recovery (FLAIR) 
images showing bilateral T2 hyperintense lesions in 
periventricular areas, adjacent bilateral centrum 
semiovale and corpus callosum (open arrows). 
FLAIR image differentiates cystic component 
from edema
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lymphohistiocytosis (HLH), progressive vacuolating 
glycine leukoencephalopathy (PVGL), progressive 
cystic leukoencephalopathy and mitochondrial 
cytopathies specifically Leigh’s syndrome.
In this case, the typical constellation of findings 
described above was suggestive of the original 
definition of PCL by Naidu et al. [3] than of a 
progressive cystic leukoencephalopathy [4]. Our case 
demonstrated some variation from classical features 
of PCL. Whereas, cystic changes in CC are a typical 
feature of PCL, our patient demonstrated solidly 
enhancing T1 hypointense lesions in CC. In view of 
diffusion restriction and intense enhancement, these 
lesions were probably active, and, were likely to show 
cystic evolution over time.
ADEM is characterized by elevated CSF protein, 
involvement of both gray and WM lesions, with 
contrast enhancement of the active lesions [5]. Cystic 
changes on MRI are unusual in ADEM. ADANE can 
mimic acute encephalopathic phase of PCL, however, 
neuroimaging shows predominant thalamic and 
brainstem involvement with elevated CSF protein; 
all of which were absent in our case [6]. Normal 
glycine levels on TMS and absence of other typical 
features ruled out PVGL [7]. Lack of macrocephaly 
excludes leukodystrophies like MLC and Alexander’s 
disease [8]. HLH has multisystem involvement, 
hematological abnormalities and meningeal 
involvement, none of which was seen in this case [9].
In our patient, episodic, acute deterioration without 
any evidence of preceding brain infections or obvious 
metabolic stress, normal HC and CSF study rules out all 
of the above mentioned conditions, with the exception 
of Leigh’s disease, especially COX deficiency and 
SURF1 mutation [10]. However the study of the 
mitochondrial genome for common deletions and 
duplications was unremarkable in this case. Moreover, 
despite the detection of elevated lactate in Naidu’s 
original series, consistent abnormalities in the 
metabolic profile, muscle respiratory chain enzymes, 
Figure 4: Magnetic resonance spectroscopy (MRS) 
findings showing features suggestive of progressive 
cavitating leukoencephalopathy. MRS showed 
elevated lactate, low N-acetyl aspartate and choline 
levels in cystic areas of the white matter (WM) 
lesions. Necrotic regions showed lactate levels 
of 30600 (More than 1.75 that of normal brain 
regions). Necrotic regions showed Ch/Cr of 0.789, 
Ch/N-acetylaspartate (NAA) of 0.674 as against 
Ch/Cr of 0.955, Ch/NAA of 1.244 in the adjacent 
normal brain. Transition zone had nearly similar 
Ch/Cr as the adjacent normal brain, whereas 
Ch/NAA was low in transition zone. Peripheral 
normal WM showed normal peaks of lactate and 
minimally reduced levels of choline and NAA
Figure 3: (a and b) Magnetic resonance imaging 
findings showing features suggestive of progressive 
cavitating leukoencephalopathy. Corpus callosal 
lesions showed restricted diffusion and low apparent 
diffusion coefficient values probably due to active 
demyelination in these regions (open arrows). Also 
noted was that, there was no significant diffusion 
restriction of lesions in the periventricular area or 
in the centrum semiovale and there was sparing of 
subcortical U fibers. The basal ganglia, thalami, 
brainstem, cerebellum and upper cervical cord 
were uninvolved
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and identifiable mitochondrial deoxyribonucleic acid 
mutations or deletions were not found [3]; similar to 
the case we describe here.
A typical case of PCL is characterized by 
episodic, acute onset of irritability or neurological 
deficits occurring between 2 months and 3.5 years 
of age, followed by steady or intermittent clinical 
deterioration. Clinical course varies from rapid 
deterioration to prolonged periods of stability, not 
predictable by clinical picture or by imaging profile. 
During periods of remission, the patients can recover 
some skills, although not to the previous levels. 
Progressive spasticity, dementia, vegetative state, 
or death ensues between 11 months and 14 years 
of age [3]. Treatment remains symptomatic and 
supportive.
CONCLUSION
To conclude, episodic encephalopathy in a child 
with leukodystrophy and cystic changes, callosal 
involvement, with focal contrast enhancement on MRI 
and lactic acidosis or lactate peak on MRS should 
lead to consideration of possible PCL, after ruling out 
above mentioned differentials.
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